| Dr Manal Anz, DPM | |
|
333 River Rd, Shelton, CT 06484-4422 | |
| (203) 924-5656 | |
| Not Available |
| Full Name | Dr Manal Anz |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 14 Years |
| Location | 333 River Rd, Shelton, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285946426 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| St. Vincent's Medical Center | Bridgeport, CT | Hospital |
| Provider Name | Optimus Health Care Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1669445946 PECOS PAC ID: 9335051580 Enrollment ID: O20031105000254 |
News Archive
A large international research group led by Dr. Tarik M-r-y, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), has discovered that a variant of the gene "Growth Factor Independence 1" (GFI1) predisposes humans to develop acute myeloid leukemia (AML), a certain subtype of blood cancer.
A recent trial of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis found the safety profile to be consistent with other RA trials with TNF inhibitors.
In six out of 10 cases, ovarian cancer is diagnosed when the disease is advanced and five-year survival is only 27 percent.
In the first Series paper, Self-harm and suicide in adolescents, Professor Keith Hawton, Dr Kate Saunders of the University of Oxford's Centre for Suicide Research, and Professor Rory O'Connor of University of Stirling's Suicidal Behaviour Research Laboratory, UK, examine existing research to look at the connections between self-harm and suicide in young people.
Allos Therapeutics, Inc. today announced that it continues to work with AMAG Pharmaceuticals, Inc. towards the completion of their merger, pending stockholder approval and satisfaction of the other conditions to closing described in Allos' definitive proxy statement filed with the SEC on September 15, 2011.
› Verified 6 days ago
| Provider Name | St. Vincent's Multispecialty Group Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1043544489 PECOS PAC ID: 6204977218 Enrollment ID: O20100112000538 |
News Archive
A large international research group led by Dr. Tarik M-r-y, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), has discovered that a variant of the gene "Growth Factor Independence 1" (GFI1) predisposes humans to develop acute myeloid leukemia (AML), a certain subtype of blood cancer.
A recent trial of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis found the safety profile to be consistent with other RA trials with TNF inhibitors.
In six out of 10 cases, ovarian cancer is diagnosed when the disease is advanced and five-year survival is only 27 percent.
In the first Series paper, Self-harm and suicide in adolescents, Professor Keith Hawton, Dr Kate Saunders of the University of Oxford's Centre for Suicide Research, and Professor Rory O'Connor of University of Stirling's Suicidal Behaviour Research Laboratory, UK, examine existing research to look at the connections between self-harm and suicide in young people.
Allos Therapeutics, Inc. today announced that it continues to work with AMAG Pharmaceuticals, Inc. towards the completion of their merger, pending stockholder approval and satisfaction of the other conditions to closing described in Allos' definitive proxy statement filed with the SEC on September 15, 2011.
› Verified 6 days ago
| Provider Name | Housatonic Valley Podiatric Center Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1528493244 PECOS PAC ID: 0547483414 Enrollment ID: O20140521001708 |
News Archive
A large international research group led by Dr. Tarik M-r-y, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), has discovered that a variant of the gene "Growth Factor Independence 1" (GFI1) predisposes humans to develop acute myeloid leukemia (AML), a certain subtype of blood cancer.
A recent trial of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis found the safety profile to be consistent with other RA trials with TNF inhibitors.
In six out of 10 cases, ovarian cancer is diagnosed when the disease is advanced and five-year survival is only 27 percent.
In the first Series paper, Self-harm and suicide in adolescents, Professor Keith Hawton, Dr Kate Saunders of the University of Oxford's Centre for Suicide Research, and Professor Rory O'Connor of University of Stirling's Suicidal Behaviour Research Laboratory, UK, examine existing research to look at the connections between self-harm and suicide in young people.
Allos Therapeutics, Inc. today announced that it continues to work with AMAG Pharmaceuticals, Inc. towards the completion of their merger, pending stockholder approval and satisfaction of the other conditions to closing described in Allos' definitive proxy statement filed with the SEC on September 15, 2011.
› Verified 6 days ago
| Provider Name | Hartford Healthcare Medical Group Specialists Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
A large international research group led by Dr. Tarik M-r-y, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), has discovered that a variant of the gene "Growth Factor Independence 1" (GFI1) predisposes humans to develop acute myeloid leukemia (AML), a certain subtype of blood cancer.
A recent trial of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis found the safety profile to be consistent with other RA trials with TNF inhibitors.
In six out of 10 cases, ovarian cancer is diagnosed when the disease is advanced and five-year survival is only 27 percent.
In the first Series paper, Self-harm and suicide in adolescents, Professor Keith Hawton, Dr Kate Saunders of the University of Oxford's Centre for Suicide Research, and Professor Rory O'Connor of University of Stirling's Suicidal Behaviour Research Laboratory, UK, examine existing research to look at the connections between self-harm and suicide in young people.
Allos Therapeutics, Inc. today announced that it continues to work with AMAG Pharmaceuticals, Inc. towards the completion of their merger, pending stockholder approval and satisfaction of the other conditions to closing described in Allos' definitive proxy statement filed with the SEC on September 15, 2011.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Manal Anz, DPM 333 River Rd, Shelton, CT 06484-4422 Ph: (203) 924-5656 | Dr Manal Anz, DPM 333 River Rd, Shelton, CT 06484-4422 Ph: (203) 924-5656 |
News Archive
A large international research group led by Dr. Tarik M-r-y, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), has discovered that a variant of the gene "Growth Factor Independence 1" (GFI1) predisposes humans to develop acute myeloid leukemia (AML), a certain subtype of blood cancer.
A recent trial of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis found the safety profile to be consistent with other RA trials with TNF inhibitors.
In six out of 10 cases, ovarian cancer is diagnosed when the disease is advanced and five-year survival is only 27 percent.
In the first Series paper, Self-harm and suicide in adolescents, Professor Keith Hawton, Dr Kate Saunders of the University of Oxford's Centre for Suicide Research, and Professor Rory O'Connor of University of Stirling's Suicidal Behaviour Research Laboratory, UK, examine existing research to look at the connections between self-harm and suicide in young people.
Allos Therapeutics, Inc. today announced that it continues to work with AMAG Pharmaceuticals, Inc. towards the completion of their merger, pending stockholder approval and satisfaction of the other conditions to closing described in Allos' definitive proxy statement filed with the SEC on September 15, 2011.
› Verified 6 days ago
B .glenn Blair Dpm P.c. Podiatrist Medicare: Medicare Enrolled Practice Location: 375 Bridgeport Ave, Shelton, CT 06484 Phone: 203-929-5559 Fax: 203-929-5277 | |
Ballard Glenn Blair, D.P.M Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 375 Bridgeport Ave, Shelton, CT 06484 Phone: 203-929-5559 Fax: 203-929-5277 | |
Housatonic Valley Podiatric Center Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 333 River Road, Shelton, CT 06484 Phone: 203-450-0144 | |
Foot And Ankle Specialists Of Ct,p.c. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 9 Cots St, Shelton, CT 06484 Phone: 203-924-4747 | |
Stephen Schmidt Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 61 Bridgeport Ave, Shelton, CT 06484 Phone: 203-924-4687 | |
Foot Andanklespecialistofct,p.c. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 9 Cots St, Shelton, CT 06484 Phone: 203-924-4747 Fax: 203-924-2495 |